Symbol="HARP"
AssetType="Common Stock"
Name="Harpoon Therapeutics Inc"
Description="Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, is involved in the development of a new class of T-cell activators that harness the power of the body's immune system to treat patients with cancer and other diseases in the United States. . The company is headquartered in South San Francisco, California."
CIK="1708493"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="131 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="31016500"
EBITDA="-34907000"
PERatio="None"
PEGRatio="None"
BookValue="0.079"
DividendPerShare="0"
DividendYield="0"
EPS="-1.63"
RevenuePerShareTTM="1.316"
ProfitMargin="-0.867"
OperatingMarginTTM="-0.799"
ReturnOnAssetsTTM="-0.27"
ReturnOnEquityTTM="-2.722"
RevenueTTM="46510000"
GrossProfitTTM="-49478000"
DilutedEPSTTM="-1.63"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.435"
AnalystTargetPrice="5.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="0.746"
PriceToBookRatio="1.493"
EVToRevenue="0.587"
EVToEBITDA="0.433"
Beta="1.548"
num_52WeekHigh="2.1"
num_52WeekLow="0.544"
num_50DayMovingAverage="0.762"
num_200DayMovingAverage="0.774"
SharesOutstanding="37595800"
DividendDate="None"
ExDividendDate="None"
symbol="HARP"
open="0.85"
high="0.85"
low="0.79"
price="0.81"
volume="135531.00"
latest_trading_day="2023-08-15"
previous_close="0.84"
change="-0.03"
change_percent="-3.5224%"
aroon_positive_momentum_days="64"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="64"
Volume_recent_avg="199262"
Change_recent_avg="0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.59"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_60"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="64"
Aroon_momentum_negative="36"
image_negative_thumbnail_id_1="1132"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0165.jpeg"
image_negative_thumbnail_id_2="487"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0118.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="579"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0020.jpeg"
image_positive_thumbnail_id_1="1004"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0166.jpeg"
image_positive_thumbnail_id_2="678"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0030.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
